5Suppliers
6Customers
2Debt Items
20Related Chains

QuidelOrtho Corporation Suppliers

TickerNameConfidenceEvidence
CONTRACT-MANUFACTURERS CONTRACT-MANUFACTURERS 90% Our reliance on 28 a small number of contract manufacturers and a large number of single and sole source suppliers makes us vulnerable to possible production capacity or other constraints of such sup…
SUPPLIERS SUPPLIERS 90% Our reliance on 28 a small number of contract manufacturers and a large number of single and sole source suppliers makes us vulnerable to possible production capacity or other constraints of such sup…
GOVERNMENT-AGENCIES GOVERNMENT-AGENCIES 80% we proactively work with our suppliers, manufacturers, distributors, industry partners and government agencies to address these challenges
INDUSTRY-PARTNERS INDUSTRY-PARTNERS 80% we proactively work with our suppliers, manufacturers, distributors, industry partners and government agencies to address these challenges
IDXX IDEXX Laboratories, Inc. 72% Reciprocal relationship from IDXX graph: to the same period for the prior year, net of the effect of changes in foreign currency exchange rates, certain business acquisitions and divestitures. Organi…

QuidelOrtho Corporation Customers

TickerNameConfidenceEvidence
GRIFOLS-DIAGNOSTIC-SOLUTIONS-INC GRIFOLS-DIAGNOSTIC-SOLUTIONS-INC 85% Joint Business collaboration arrangement between Ortho and Grifols
ABT Abbott Laboratories 72% s. Some of our principal competitors include, among others, Abbott Laboratories, bioMérieux, Bio-Rad, Danaher, Diasorin, Hologic, Qiagen, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientifi…
ABT Abbott Laboratories 72% Reciprocal relationship from ABT graph: Reciprocal relationship from QDEL graph: s. Some of our principal competitors include, among others, Abbott Laboratories, bioMérieux, Bio-Rad, Danaher, Diasori…
BRAZILIAN-CLEAN-COMPANY BRAZILIAN-CLEAN-COMPANY 62% azilian Anti-Bribery Act (also known as the Brazilian Clean Company Act) and various other similar anti-corruption and anti-bribery laws. These laws generally prohibit us and our intermediaries from,…
DELAWARE-GENERAL-CORPORATION DELAWARE-GENERAL-CORPORATION 62% matters, may impose additional costs on us and expose us to new risks. There is an increasing focus and scrutiny from regulators, investors, customers, suppliers, vendors, employees and other stakeho…
VZV-GROUP VZV-GROUP 62% ing range across over 60 immunoassay tests. Reagents are packaged in ready-to-use integrated packs that can be loaded continuously while testing is underway for high-throughput applications. These in…

QuidelOrtho Corporation Debt Obligations

InstrumentDescriptionConfidenceEvidence
QDEL-DEBT Debt stack $2.9B 90% Market cache reports total debt of $2.9B.
QDEL-DEBT-11979 Xbrl Convertible 90% xbrl convertible detail from xbrl 2023-01-01.

QuidelOrtho Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for QuidelOrtho Corporation.

QuidelOrtho Corporation Ownership

HolderNameConfidenceEvidence
QDEL-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 243 tracked holders.

QuidelOrtho Corporation Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
NBP NovaBridge Biosciences 100.00 2
MTLS Materialise NV 100.00 2
ITGR Integer Holdings Corporation 100.00 2
IINN Inspira Technologies Oxy B.H.N. Ltd. 100.00 2
GRAL GRAIL, Inc. 100.00 2
NVS Novartis AG 100.00 2
GIFOF Grifols, S.A. 100.00 2
GIFLF Grifols, S.A. 100.00 2
AORT Artivion, Inc. 100.00 2
IVA Inventiva S.A. 100.00 2
VTAK Catheter Precision, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
GRFS Grifols, S.A. 100.00 2
GCTK GlucoTrack, Inc. 100.00 2
FLGT Fulgent Genetics, Inc. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
GIKLY Grifols, S.A. 100.00 2
ALVO Alvotech 100.00 2
EXAS Exact Sciences Corp 100.00 2
NSPR InspireMD, Inc. 100.00 2